Abstract: Acidic liquid fabric care compositions that include citric acid and/or a salt thereof, a nonionic surfactant that has a Stability Parameter between 11.0 and 25.0, and water. Related methods of using and making such compositions.

Abstract: Medication delivery methods, devices and systems are provided. The medication delivery device includes a retractable sheath mechanism connected to a distal end of the device. The retractable sheath mechanism is axially movable between a first position to cover a needle attached to the distal end and a second position to expose the needle with an adjustable protrusion length. The retractable sheath mechanism includes one or more skin sensors disposed on an end surface thereof to detect skin before and during injection. In some cases, a needle carousel is provided to connect to the distal end of the device. The needle carousel supports multiple needle capsules each including a needle.

Abstract: The instant invention provides various formulations comprising combinations of immunostimulating oligonucleotides, polycationic carriers, sterols, saponins, quaternary amines, TLR-3 agonists, glycolipids, and MPL-A or analogs thereof in oil emulsions, use thereof in preparations of immunogenic compositions and vaccines, and use thereof in the treatment of animals.

Abstract: A sharpener for a writing instrument includes a receptacle, an entry assembly, and a cutter assembly. The entry assembly is coupled to the receptacle and defines an instrument opening. The entry assembly is configured to receive an end of the writing instrument through the instrument opening along an entry axis. The cutter assembly is configured to revolve about the entry axis in engagement with the entry assembly to sharpen the end of the writing instrument. The cutter assembly is removably engageable with the entry assembly at least by relative translation between the cutter assembly and the receptacle along the entry axis.

Abstract: A method for an unsafe speed intervention system is described. The method includes determining whether an initial speed of a vehicle is unsafe. The method also includes displaying an augmented reality pattern on a windshield of the vehicle moving at a selected speed in response to determining the initial speed of the vehicle is unsafe. The method further includes monitoring a current speed of the vehicle after displaying the augmented reality pattern. The method also includes adjusting the selected speed of the augmented reality pattern displayed on the vehicle windshield in response to the monitoring the current speed of the vehicle.

Abstract: A sharpener for a writing instrument includes a receptacle, an entry assembly, and a cutter assembly. The entry assembly is coupled to the receptacle and defines an instrument opening. The entry assembly is configured to receive an end of the writing instrument through the instrument opening along an entry axis. The cutter assembly is configured to revolve about the entry axis in engagement with the entry assembly to sharpen the end of the writing instrument. The cutter assembly is removably engageable with the entry assembly at least by relative translation between the cutter assembly and the receptacle along the entry axis.

Abstract: Provided are MOF-fabric composites having a crystalline MOF adhered directly to fibers of the fabric and methods of making MOF-fabric composites. A solution is adsorbed onto a fabric. The solution can include a metal salt, a linker, and a solvent. The solution is adsorbed onto the fabric and the fabric suspended over a heated vapor. The vapor releases onto the fabric, causing the metal salt, the linker, and the solvent to diffuse out of the polymer fibers. The linker links metal from the metal salts to form crystals attached to the fabric, and the vapor aids crystallization.

Abstract: A lighting module comprises a light source, an optical mixing element or chamber and a spectral converting diffuser for tuning the wavelength and spatially homogenising the intensity of the ouptut light from the light source. Also disclosed is a method of improving Colour Rendering Index (CRI) of a lighting device that includes coupling the lighting module with the lighting device. Use of the lighting module in conjunction with a lighting device is also described.

Abstract: Apparatus, methods and systems are provided for improving the quality of illumination from a luminaire. The apparatus, methods and systems provide quantum dots, methods and apparatus for stimulating device light emission from quantum dots, sensors, and controllers to adjust quality of illumination from a luminaire.

Abstract: Described herein is a transparent or translucent substrate at least partially coated with a quantum dot coating such that the coating is invisible in a first non-excited state of the coating and the coating is visible in a second excited state of the coating. Also described herein is a laminate, a glazing unit and a sunroof comprising the described coated substrate. A method of preparing the coated substrate is also described.

Abstract: The present invention provides formulations and methods for formulation administration that support an individual's body during vaccination and adaptive immune response. The individuals who can benefit from these formulations and methods for formulation administration are infants, children and adults. The formulations comprise ingredients that may be administered prior to, concurrent with or subsequent to the vaccination. The formulations and methods for formulation administration of the present invention preferably act by selectively targeting enzymatic reactions, epigenetic expression, and an individual's various metabolic pathways in support of immune system homeostasis, maintaining balance between oxidative stress and methylation, fostering balance between Th1 and Th2 responses, or a combination thereof, during vaccination and adaptive immune responses to improve vaccine response and reduce vaccine side effects.

Abstract: Apparatus, methods and systems are provided for improving the quality of illumination from a luminaire. The apparatus, methods and systems provide quantum dots, methods and apparatus for stimulating device light emission from quantum dots, sensors, and controllers to adjust quality of illumination from a luminaire.

Abstract: The present invention provides formulations and methods for formulation administration that support an individual's body during vaccination and adaptive immune response. The individuals who can benefit from these formulations and methods for formulation administration are infants, children and adults. The formulations comprise ingredients that may be administered prior to, concurrent with or subsequent to the vaccination. The formulations and methods for formulation administration of the present invention preferably act by selectively targeting enzymatic reactions, epigenetic expression, and an individual's various metabolic pathways in support of immune system homeostasis, maintaining balance between oxidative stress and methylation, fostering balance between Th1 and Th2 responses, or a combination thereof, during vaccination and adaptive immune responses to improve vaccine response and reduce vaccine side effects.

Abstract: Apparatus, methods and systems are provided for improving the quality of illumination from a luminaire. The apparatus, methods and systems provide quantum dots, methods and apparatus for stimulating device light emission from quantum dots, sensors, and controllers to adjust quality of illumination from a luminaire.

Abstract: Described herein is a transparent or translucent substrate at least partially coated with a quantum dot coating such that the coating is invisible in a first non-excited state of the coating and the coating is visible in a second excited state of the coating. Also described herein is a laminate, a glazing unit and a sunroof comprising the described coated substrate. A method of preparing the coated substrate is also described.

Abstract: The present invention relates to a combination nutrient supplement directed to the remuneration of nutritional deficiencies and biochemical imbalances, directly or indirectly, related to the use of exogenous hormones. The unique nutritional supplement that is the present invention is directed toward supporting the unique deficiencies of women taking exogenous hormones (e.g. hormonal contraceptives and hormone replacement) which supplant an identified subset of depleted and essential vitamins and minerals deficient in those women taking exogenous hormones which are vital to providing for a woman's health, wellness and overall homeostatic state.

Abstract: A light module comprises a light source, an optical mixing element or chamber and a spectral converting diffuser for tuning the wavelength and spatially homogenising the intensity of the ouptut light from the light source. Also disclosed is a method of improving Colour Rendering Index (CRI) of a lighting device. The disclosed lighting module is coupled with the lighting device. Use of the disclosed lighting module in conjunction with a lighting device is also described.

Abstract: The present invention provides formulations that support an individual's body during routine vaccination and adaptive immune response. The individuals who can benefit from these formulations are infants, children and adults. The formulations comprise ingredients that can be administered prior to, concurrent with or subsequent to the vaccination. The formulations of the present invention preferably act by targeting enzymatic reactions an individual's various metabolic pathways, maintaining balance between oxidative stress and methylation, maintaining balance between Th1 and Th2 responses, or a combination thereof during vaccination and adaptive immune response.

Abstract: The present invention provides formulations that support an individual's body during routine vaccination and adaptive immune response. The individuals who can benefit front these formulations are infants, children and adults. The formulations comprise ingredients that can be administered prior to, concurrent with or subsequent to the vaccination. The formulations of the present invention preferably act by targeting enzymatic reactions an individual's various metabolic pathways, maintaining balance between oxidative stress and methylation, maintaining balance between Th1 and Th2 responses, or a combination thereof during vaccination and adaptive immune response.